Contact Us | Home
Toll Free No. for USA/Canada:   1-866-279-8368
| Advance Search
 
Currency:  $ £
Discounted Reports
MARKET RESEARCH SECTOR IN FOCUS
Energy & Resources
FMCG & Retailing
Pharmaceuticals and Healthcare
Textiles
MARKET REPORT DETAIL

Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H2, 2013

Enquire | Email | Print

ISBN: GDHC1928CTIDB
Published Date: Dec, 2013
Format: PDF
No of Pages: 74
 
 
Select pricing :
Change Currency: EURO | $ USD | £ GBP
Buy through us and save. We do not add any Tax / Duty including VAT,GST
  • Abstract
  • Table of Contents

Summary

“Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H2, 2013" provides data on the Wilms’ Tumor (Nephroblastoma) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Wilms’ Tumor (Nephroblastoma). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Wilms’ Tumor (Nephroblastoma). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Wilms' Tumor (Nephroblastoma) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Wilms' Tumor (Nephroblastoma) 23
Subjects Recruited Over a Period of Time 25
Prominent Sponsors 26
Top Companies Participating in Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials 27
Prominent Drug Comparison 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Talon Therapeutics, Inc. 29
Clinical Trial Overview of Talon Therapeutics, Inc. 29
Laboratorio Elea S.A.C.I.F. and A 30
Clinical Trial Overview of Laboratorio Elea S.A.C.I.F. and A 30
Jennerex Biotherapeutics, Inc. 31
Clinical Trial Overview of Jennerex Biotherapeutics, Inc. 31
Clinical Trial Overview of Top Institutes / Government 32
Children's Oncology Group 32
Clinical Trial Overview of Children's Oncology Group 32
National Cancer Institute 34
Clinical Trial Overview of National Cancer Institute 34
St. Jude Children’s Research Hospital, Inc. 36
Clinical Trial Overview of St. Jude Children’s Research Hospital, Inc. 36
The University of Texas M. D. Anderson Cancer Center 37
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 37
Cancer Research UK 38
Clinical Trial Overview of Cancer Research UK 38
Memorial Sloan Kettering Cancer Center 39
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 39
Emory University 40
Clinical Trial Overview of Emory University 40
University of Michigan Comprehensive Cancer Center 41
Clinical Trial Overview of University of Michigan Comprehensive Cancer Center 41
Dana-Farber Cancer Institute, Inc. 42
Clinical Trial Overview of Dana-Farber Cancer Institute, Inc. 42
University Hospitals of Leicester NHS Trust 43
Clinical Trial Overview of University Hospitals of Leicester NHS Trust 43
Five Key Clinical Profiles 44
Appendix 72
Abbreviations 72
Definitions 72
Research Methodology 73
Secondary Research 73
About GlobalData 73
Contact Us 74
Disclaimer 74
Source 74

List of Tables
Wilms' Tumor (Nephroblastoma) Therapeutics Market, Global, Clinical Trials by Zone, 2013* 7
Wilms' Tumor (Nephroblastoma) Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Wilms' Tumor (Nephroblastoma) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 10
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 11
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, North America, Top Countries, 2013* 12
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 13
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Central and South America, Top Countries, 2013* 14
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, BRIC Countries, 2013* 15
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, G7 Countries, 2013* 16
Wilms' Tumor (Nephroblastoma) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, E7 Countries, 2013* 18
Wilms' Tumor (Nephroblastoma) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
Wilms' Tumor (Nephroblastoma) Therapeutics Market, Global, Clinical Trials by Phase, 2013* 20
Wilms' Tumor (Nephroblastoma) Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 21
Wilms' Tumor (Nephroblastoma) Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
Wilms' Tumor (Nephroblastoma) Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 23
Wilms' Tumor (Nephroblastoma) Therapeutics Market, Global, Terminated Clinical Trials, 2013* 24
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 25
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 26
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 27
Wilms’ Tumor Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 28
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Talon Therapeutics, Inc., 2013* 29
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratorio Elea S.A.C.I.F. and A, 2013* 30
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Jennerex Biotherapeutics, Inc., 2013* 31
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2013* 32
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2013* 34
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Children’s Research Hospital, Inc., 2013* 36
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2013* 37
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Cancer Research UK, 2013* 38
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2013* 39
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2013* 40
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan Comprehensive Cancer Center, 2013* 41
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, Inc., 2013* 42
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals of Leicester NHS Trust, 2013* 43

List of Figures
Wilms' Tumor (Nephroblastoma) Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 7
Wilms' Tumor (Nephroblastoma) Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Wilms' Tumor (Nephroblastoma) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 10
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 11
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 12
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 13
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, G7 Countries (%), 2013* 16
Wilms' Tumor (Nephroblastoma) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Wilms' Tumor (Nephroblastoma) Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 20
Wilms' Tumor (Nephroblastoma) Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 21
Wilms' Tumor (Nephroblastoma) Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 25
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 26
Wilms' Tumor (Nephroblastoma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 27
Wilms’ Tumor Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 28
GlobalData Methodology 73

Related Reports:  

 

Custom Research
If above report doesn't have the business information suitable for your business, we can provide custom research that would be lucrative for your business or enhance your profession. We leverage most comprehensive, affordable, high-quality custom research which will match exact topic & specifications of your choice. Please visit Custom Research page to make an enquiry.

 

Top Go to top of the page

product id: 218809, price: INR 151309, GlobalData

International Travel Grant for Members of
MANLIBNET (Management Libraries Network)
We accept
Phone: +91.22.27810772, 27810773
E-mail: info@bharatbook.com
Hours: Mon to Sat 8:00 AM to 8:00 PM IST
Call USA/Canada 1-866-279-8368
 
GPlus
About Trust Online